165 related articles for article (PubMed ID: 38520039)
1. Metformin and other anti-diabetic medication use and breast cancer incidence in the Nurses' Health Studies.
Wang T; Chai B; Chen WY; Holmes MD; Erdrich J; Hu FB; Rosner BA; Tamimi RM; Willett WC; Kang JH; Eliassen AH
Int J Cancer; 2024 Jul; 155(2):211-225. PubMed ID: 38520039
[TBL] [Abstract][Full Text] [Related]
2. A prospective study of type 2 diabetes, metformin use, and risk of breast cancer.
Park YM; Bookwalter DB; O'Brien KM; Jackson CL; Weinberg CR; Sandler DP
Ann Oncol; 2021 Mar; 32(3):351-359. PubMed ID: 33516778
[TBL] [Abstract][Full Text] [Related]
3. Type 2 diabetes, breast cancer specific and overall mortality: Associations by metformin use and modification by race, body mass, and estrogen receptor status.
Lee KN; Torres MA; Troeschel AN; He J; Gogineni K; McCullough LE
PLoS One; 2020; 15(5):e0232581. PubMed ID: 32369516
[TBL] [Abstract][Full Text] [Related]
4. Comparative safety of diabetes medications and risk of incident invasive breast cancer: a population-based cohort study.
Calip GS; Yu O; Elmore JG; Boudreau DM
Cancer Causes Control; 2016 May; 27(5):709-20. PubMed ID: 27053250
[TBL] [Abstract][Full Text] [Related]
5. Association of antidiabetic medication and statins with breast cancer incidence in women with type 2 diabetes.
Hosio M; Urpilainen E; Marttila M; Hautakoski A; Arffman M; Sund R; Puistola U; Läärä E; Jukkola A; Karihtala P
Breast Cancer Res Treat; 2019 Jun; 175(3):741-748. PubMed ID: 30895533
[TBL] [Abstract][Full Text] [Related]
6. Olive oil consumption and risk of type 2 diabetes in US women.
Guasch-Ferré M; Hruby A; Salas-Salvadó J; Martínez-González MA; Sun Q; Willett WC; Hu FB
Am J Clin Nutr; 2015 Aug; 102(2):479-86. PubMed ID: 26156740
[TBL] [Abstract][Full Text] [Related]
7. Antidiabetic medication, statins and the risk of endometrioid endometrial cancer in patients with type 2 diabetes.
Arima R; Marttila M; Hautakoski A; Arffman M; Sund R; Ilanne-Parikka P; Kangaskokko J; Läärä E; Puistola U; Hinkula M
Gynecol Oncol; 2017 Sep; 146(3):636-641. PubMed ID: 28645427
[TBL] [Abstract][Full Text] [Related]
8. Type II Diabetes and Incidence of Estrogen Receptor Negative Breast Cancer in African American Women.
Palmer JR; Castro-Webb N; Bertrand K; Bethea TN; Denis GV
Cancer Res; 2017 Nov; 77(22):6462-6469. PubMed ID: 29141994
[TBL] [Abstract][Full Text] [Related]
9. The role of metformin and statins in the incidence of epithelial ovarian cancer in type 2 diabetes: a cohort and nested case-control study.
Urpilainen E; Marttila M; Hautakoski A; Arffman M; Sund R; Ilanne-Parikka P; Arima R; Kangaskokko J; Puistola U; Läärä E; Hinkula M
BJOG; 2018 Jul; 125(8):1001-1008. PubMed ID: 29412502
[TBL] [Abstract][Full Text] [Related]
10. Antidiabetic Medication, Statins and the Risk and Prognosis of Non-endometrioid Endometrial Cancer in Women with Type 2 Diabetes.
Arima R; Marttila M; Hautakoski A; Arffman M; Sund R; Ilanne-Parikka P; Kangaskokko J; Urpilainen E; Läärä E; Hinkula M; Puistola U
Anticancer Res; 2018 Jul; 38(7):4169-4178. PubMed ID: 29970546
[TBL] [Abstract][Full Text] [Related]
11. Type 2 diabetes and obesity in midlife and breast cancer risk in the Reykjavik cohort.
Maskarinec G; Haraldsdóttir Á; Einarsdóttir K; Aspelund T; Tryggvadóttir L; Harris TB; Gudnason V; Torfadóttir JE
Cancer Causes Control; 2019 Oct; 30(10):1057-1065. PubMed ID: 31401707
[TBL] [Abstract][Full Text] [Related]
12. Metformin Treatment and Cancer Risk: Cox Regression Analysis, With Time-Dependent Covariates, of 320,000 Persons With Incident Diabetes Mellitus.
Dankner R; Agay N; Olmer L; Murad H; Keinan Boker L; Balicer RD; Freedman LS
Am J Epidemiol; 2019 Oct; 188(10):1794-1800. PubMed ID: 31269196
[TBL] [Abstract][Full Text] [Related]
13. Incident Type 2 Diabetes Duration and Cancer Risk: A Prospective Study in Two US Cohorts.
Hu Y; Zhang X; Ma Y; Yuan C; Wang M; Wu K; Tabung FK; Tobias D; Hu FB; Giovannucci E; Song M
J Natl Cancer Inst; 2021 Apr; 113(4):381-389. PubMed ID: 33225344
[TBL] [Abstract][Full Text] [Related]
14. Pioglitazone and breast cancer risk in female patients with type 2 diabetes mellitus: a retrospective cohort analysis.
Tseng CH
BMC Cancer; 2022 May; 22(1):559. PubMed ID: 35585577
[TBL] [Abstract][Full Text] [Related]
15. Diabetes, metformin and incidence of and death from invasive cancer in postmenopausal women: Results from the women's health initiative.
Gong Z; Aragaki AK; Chlebowski RT; Manson JE; Rohan TE; Chen C; Vitolins MZ; Tinker LF; LeBlanc ES; Kuller LH; Hou L; LaMonte MJ; Luo J; Wactawski-Wende J
Int J Cancer; 2016 Apr; 138(8):1915-27. PubMed ID: 26616262
[TBL] [Abstract][Full Text] [Related]
16. History of Gestational Diabetes Mellitus and Risk of Incident Invasive Breast Cancer among Parous Women in the Nurses' Health Study II Prospective Cohort.
Powe CE; Tobias DK; Michels KB; Chen WY; Eliassen AH; Manson JE; Rosner B; Willett WC; Hu FB; Zhang C; Rich-Edwards JW; Rexrode KM
Cancer Epidemiol Biomarkers Prev; 2017 Mar; 26(3):321-327. PubMed ID: 27729356
[No Abstract] [Full Text] [Related]
17. Metformin reduces the risk of cancer in patients with type 2 diabetes: An analysis based on the Korean National Diabetes Program Cohort.
Kim HJ; Lee S; Chun KH; Jeon JY; Han SJ; Kim DJ; Kim YS; Woo JT; Nam MS; Baik SH; Ahn KJ; Lee KW
Medicine (Baltimore); 2018 Feb; 97(8):e0036. PubMed ID: 29465545
[TBL] [Abstract][Full Text] [Related]
18. Diabetes, metformin, and breast cancer in postmenopausal women.
Chlebowski RT; McTiernan A; Wactawski-Wende J; Manson JE; Aragaki AK; Rohan T; Ipp E; Kaklamani VG; Vitolins M; Wallace R; Gunter M; Phillips LS; Strickler H; Margolis K; Euhus DM
J Clin Oncol; 2012 Aug; 30(23):2844-52. PubMed ID: 22689798
[TBL] [Abstract][Full Text] [Related]
19. Comparative Effect of Initiating Metformin Versus Sulfonylureas on Breast Cancer Risk in Older Women.
Hong JL; Jonsson Funk M; Buse JB; Henderson LM; Lund JL; Pate V; Stürmer T
Epidemiology; 2017 May; 28(3):446-454. PubMed ID: 28166101
[TBL] [Abstract][Full Text] [Related]
20. Survival after breast cancer in women with type 2 diabetes using antidiabetic medication and statins: a retrospective cohort study.
Hosio M; Urpilainen E; Hautakoski A; Marttila M; Arffman M; Sund R; Ahtikoski A; Puistola U; Karihtala P; Jukkola A; Läärä E
Acta Oncol; 2020 Sep; 59(9):1110-1117. PubMed ID: 32478629
[No Abstract] [Full Text] [Related]
[Next] [New Search]
